Natural Anti-Metastatic Support
Modified Citrus Pectin (MCP) is derived from pectin, a high molecular-weight polysaccharide present in the cell wall of all plants. Pectin can be pH degraded to produce a modified (smaller) polysaccharide – modified citrus pectin – which has anti-metastatic properties. MCP appears to bind with galactans on cancer cell surfaces, inhibiting aggregation and adherence to normal cells and offering anti-metastatic protection in animal models.
Modified citrus pectin is readily absorbed in the GI tract and is completely non-toxic to humans. Although there are no good studies to verify MCP’s effectiveness in humans, animal studies repeatedly demonstrate MCP’s anti-metastatic capabilities. Because of the lack of toxicity of modified citrus pectin, and because conventional medicine has no drug or treatment to prevent metastasis, I recommend taking either MCP or larch in cases of cancer to help prevent or delay metastasis.
Dose: 2-3 teaspoons, 3 times daily. This may be added to your Super Shake or other beverage.
REFERENCES
1.) Guess BW, Scholz MC,Strum SB,LamRY, Johnson HJ, Jennrich RI. Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study.Prostate Cancer and Prostatic Diseases (2003) 6, 301–304. doi:10.1038/sj.pcan.4500679
2.) Nangia-Makker P, Hogan V, Honjo Y, et al. Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin. J Natl Cancer Inst. 2002;94:1854-1862.
3.) Strum S, Scholz M, McDermed J, et al. Modified citrus pectin slows PSA doubling time: A pilot clinical trial. Presentation: International Conference on Diet and Prevention of Cancer, Tampere, Finland. May 28, 1999 – June 2, 1999.
4.) Yan J, Katz AE. PectaSol-C Modified Citrus Pectin Induces Apoptosis and Inhibition of Proliferation in Human and Mouse Androgen-Dependent and Independent Prostate Cancer Cells. Integr Cancer Ther. 2010. http://www.ncbi.nlm.nih.gov/pubmed/20462856
